EMA’s Brexit plans ensure Agency’s focus on medicines evaluation and supervision

November 13, 2018 – A PDF iconreport on EMA’s 24 September 2018 meeting with industry stakeholders to discuss the UK’s withdrawal from the European Union and the impact on the operation of the centralised procedure for human and veterinary medicines, published today, outlines how the European medicines regulatory network is preparing for Brexit, including EMA’s relocation and business continuity planning. At the meeting, participants were updated on … (leggi tutto)